Dow Up0.07% Nasdaq Up0.61%

Immune Pharmaceuticals, Inc. (IMNP)

-NasdaqCM
2.62 0.13(4.73%) Nov 26, 3:59PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate0.01N/A-0.54-0.07
No. of Analysts1.00N/A1.001.00
Low Estimate0.01N/A-0.54-0.07
High Estimate0.01N/A-0.54-0.07
Year Ago EPS-0.29-0.35-0.94-0.54
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate3.50MNaN3.50M12.00M
No. of Analysts111
Low Estimate3.50MNaN3.50M12.00M
High Estimate3.50MNaN3.50M12.00M
Year Ago SalesNaNNaN19.00K3.50M
Sales Growth (year/est)N/AN/A18,321.10%242.90%
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est-0.22-0.30-0.20-0.18
EPS Actual-0.29-0.35-0.03-0.54
Difference-0.07-0.050.17-0.36
Surprise %-31.80%-16.70%85.00%-200.00%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Current Estimate0.01N/A-0.54-0.07
7 Days Ago0.13N/A-0.500.07
30 Days Ago0.13N/A-0.500.07
60 Days Ago0.13N/A-0.500.07
90 Days Ago0.13N/A-0.500.07
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0N/A00
Up Last 30 Days0N/A00
Down Last 30 Days0N/A00
Down Last 90 DaysN/AN/AN/AN/A
Growth EstIMNPIndustrySectorS&P 500
Current Qtr.103.40%N/A-72.80%18.70%
Next Qtr.N/A85.60%-36.60%18.90%
This Year42.60%26.00%30.90%7.90%
Next Year87.00%30.00%21.60%10.70%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A11.81%14.40%9.81%
Price/Earnings (avg. for comparison categories)-5.0916.344.8021.09
PEG Ratio (avg. for comparison categories)N/A0.963.743.21
Currency in USD.